Terms: = Lymphoma AND EIF3E, eIF3-p46, 3646, ENSG00000104408, EIF3S6, eIF3e, EIF3-P48, INT6
10 results:
1. Focused CRISPR-Cas9 genetic screening reveals USO1 as a vulnerability in B-cell acute lymphoblastic leukemia.
Jaiswal AK; Truong H; Tran TM; Lin TL; Casero D; Alberti MO; Rao DS
Sci Rep; 2021 Jun; 11(1):13158. PubMed ID: 34162911
[TBL] [Abstract] [Full Text] [Related]
2. MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic large cell lymphoma.
Sinatkas V; Stathopoulou K; Xagoraris I; Ye J; Vyrla D; Atsaves V; Leventaki V; Medeiros LJ; Rassidakis GZ; Drakos E
Leuk Lymphoma; 2021 Jul; 62(7):1563-1573. PubMed ID: 33569988
[TBL] [Abstract] [Full Text] [Related]
3. Fertility-preservation counselling and treatment for medical reasons: data from a multinational network of over 5000 women.
von Wolff M; Dittrich R; Liebenthron J; Nawroth F; Schüring AN; Bruckner T; Germeyer A
Reprod Biomed Online; 2015 Nov; 31(5):605-12. PubMed ID: 26380870
[TBL] [Abstract] [Full Text] [Related]
4. Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.
Jaeger U; Trneny M; Melzer H; Praxmarer M; Nawarawong W; Ben Yehuda D; Goldstein D; Mihaljevic B; Ilhan O; Ballova V; Hedenus M; Hsiao LT; Au WY; Burgstaller S; Weidinger G; Keil F; Dittrich C; Skrabs C; Klingler A; Chott A; Fridrik MA; Greil R;
Haematologica; 2015 Jul; 100(7):955-63. PubMed ID: 25911553
[TBL] [Abstract] [Full Text] [Related]
5. Cancer incidence in Khartoum, Sudan: first results from the Cancer Registry, 2009-2010.
Saeed IE; Weng HY; Mohamed KH; Mohammed SI
Cancer Med; 2014 Aug; 3(4):1075-84. PubMed ID: 24821265
[TBL] [Abstract] [Full Text] [Related]
6. Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma.
Ise T; Nagata S; Kreitman RJ; Wilson WH; Wayne AS; Stetler-Stevenson M; Bishop MR; Scheinberg DA; Rassenti L; Kipps TJ; Kyle RA; Jelinek DF; Pastan I
Leukemia; 2007 Jan; 21(1):169-74. PubMed ID: 17051241
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders.
Capello D; Cerri M; Muti G; Lucioni M; Oreste P; Gloghini A; Berra E; Deambrogi C; Franceschetti S; Rossi D; Alabiso O; Morra E; Rambaldi A; Carbone A; Paulli M; Gaidano G
Hematol Oncol; 2006 Dec; 24(4):212-9. PubMed ID: 16897790
[TBL] [Abstract] [Full Text] [Related]
8. Treatment of early clinically staged Hodgkin's disease with a combination of ABVD chemotherapy plus limited field radiotherapy.
Karmiris TD; Grigoriou E; Tsantekidou M; Spanou E; Mihalakeas H; Baltadakis J; Apostolidis J; Pagoni M; Karakasis D; Bakiri M; Mitsouli C; Harhalakis N; Nikiforakis E
Leuk Lymphoma; 2003 Sep; 44(9):1523-8. PubMed ID: 14565654
[TBL] [Abstract] [Full Text] [Related]
9. WNT and FGF gene clusters (review).
Katoh M
Int J Oncol; 2002 Dec; 21(6):1269-73. PubMed ID: 12429977
[TBL] [Abstract] [Full Text] [Related]
10. EBVD and alternating MOPP/EBVD with or without localized field radiotherapy in advanced or unfavorably presenting Hodgkin's disease.
Pogliani EM; Deliliers GL; Baldini L; Tosi A; Butti C; Chiorboli O; Confalonieri C; Fava S; Giorgetti MC; Maioli M; Maiolo AT; Marinoni P; Montalbetti L; Mozzana R; Pavia G; Pinotti G; Rossini F; Vanoli P; Venco A; Cassi E
Haematologica; 1996; 81(1):8-14. PubMed ID: 8900846
[TBL] [Abstract] [Full Text] [Related]
